Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Xoma Royalty Corp

XOMA ✓ COMPLIANT ☆ Track — members

Nasdaq · Consumer Cyclicals · Entertainment Production ·

USA Small Cap Analyst: N/A

Last Close

$40.17

▲ +0.00%

Market Cap $710.16M · Vol 2.78M

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$710.16M

Small Cap

Div Yield

N/A

Dividend with no set frequency

EPS Growth

N/A

YoY

RSI (14)

38.85

Momentum

Beta

0.88

vs Market

52W High

$45.15

11.03% below

52W Low

$22.39

79.41% above

Volume

2.78M

Avg 135.61K

P/B

3.76

Price-to-book

ROE

N/A

Return on equity

Free Float

98.69%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Xoma Royalty Corp (XOMA) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does XOMA pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-8.48%

-3.88%

+1.93%

+36.82%

YTD

+51.07%

+44.70%

+159.83%

+24.02%

Financials & Valuation

TTM · Annual

Total Revenue	$52.15M
Net Income	$31.71M
Revenue Growth (YoY)	-22.59%
Gross Margin	100.00%
Operating Margin	21.83%
Net Profit Margin	60.81%
ROE	N/A
ROA · ROIC	12.88% · 21.64%

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	0.10
P/S	9.17
P/B	3.76
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	17.68M

Technical Indicators

50-Day SMA	$42.04
200-Day SMA	$33.72
RSI (14)	38.85
Beta	0.88
52-Week High	$45.15
52-Week Low	$22.39

Volume Today	2.78M
Avg Daily Volume (30D)	135.61K
Relative Volume	20.47x
Volatility (10D)	50.86
Volatility (30D)	30.26
Free Float	98.69%

Analyst Consensus

N/A

Current Price $40.17

Mean Target N/A

52W Low$22.39 52W High$45.15

Current

Target

$22.39 $45.15

Current Analyst target

· 0 analysts

Identifiers

ExchangeNasdaq

FIGIBBG001S5XLP5

ISINUS98419J2069

CountryUnited States of America

Sub-IndustryCopyright Management

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

FRAN.L Franchise Brands PLC +0.49% 7094.T NexTone Inc -1.45% REFR Research Frontiers Inc -1.11% TRT.L Transense Technologies PLC +0.00% BOL.PA Bollore SE +0.73%

Company Profile

XOMA Royalty Corporation is a biotechnology royalty aggregator. The Company’s royalty aggregator business is primarily focused on early to mid-stage clinical assets, primarily in Phase I and II, with significant commercial sales potential that are licensed to funded partners. The Company has a portfolio of economic rights and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The Company's commercial assets include OJEMDA (tovorafenib), IXINITY, XACIATO, VABYSMO (faricimab svoa), DSUVIA (sufentanil sublingual tablet), and MIPLYFFA (arimoclomol). Its Phase III assets include Rilvegostomig (AZD2936), Ficlatuzumab (AV-299), Ovaprene, D-Fi (FCX-007), Seralutinib, Cetrelimab (JNJ-63723283), Ersodetug (RZ358), and Mezagitamab (TAK-079). Its Phase II assets include Acimtamig (AFM13), AFM24, Vosaroxin, Aldoxorubicin, G03-52-01, PBF-680, PBF-677, Vidutolimod (CMP-001), and RZ-402. Its others assets include COM902 and MT-0169.